NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis $52.53 -0.43 (-0.81%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$52.54 +0.01 (+0.02%) As of 08/7/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About RadNet Stock (NASDAQ:RDNT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RadNet alerts:Sign Up Key Stats Today's Range$50.76▼$54.5750-Day Range$52.53▼$59.2952-Week Range$45.00▼$93.65Volume1.06 million shsAverage Volume664,268 shsMarket Capitalization$3.94 billionP/E RatioN/ADividend YieldN/APrice Target$69.60Consensus RatingStrong Buy Company Overview RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. Read More RadNet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreRDNT MarketRank™: RadNet scored higher than 82% of companies evaluated by MarketBeat, and ranked 174th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingStrong Buy Consensus RatingRadNet has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 1 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-5.36% Earnings GrowthEarnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -122.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -122.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 3.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.64% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 9.6.Change versus previous monthShort interest in RadNet has recently decreased by 1.97%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Sustainability and ESG4.6 / 5Environmental Score-0.52 Percentage of Shares Shorted8.64% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 9.6.Change versus previous monthShort interest in RadNet has recently decreased by 1.97%, indicating that investor sentiment is improving. News and Social Media2.3 / 5News Sentiment1.06 News SentimentRadNet has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for RadNet this week, compared to 7 articles on an average week.MarketBeat FollowsOnly 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,613,220.00 in company stock.Percentage Held by InsidersOnly 5.60% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Stock News HeadlinesDeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™August 7 at 6:31 PM | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and Radnet (RDNT)August 5 at 8:44 PM | theglobeandmail.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. | Porter & Company (Ad)3 Reasons to Avoid RDNT and 1 Stock to Buy InsteadJuly 30, 2025 | finance.yahoo.comRadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call | RDNT ...July 25, 2025 | gurufocus.comRadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference CallJuly 25, 2025 | globenewswire.comRadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCADJuly 17, 2025 | finance.yahoo.comRadNet Completes Acquisition of iCAD for AI ExpansionJuly 17, 2025 | tipranks.comSee More Headlines RDNT Stock Analysis - Frequently Asked Questions How have RDNT shares performed this year? RadNet's stock was trading at $69.84 at the start of the year. Since then, RDNT stock has decreased by 24.8% and is now trading at $52.53. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) released its quarterly earnings results on Thursday, February, 27th. The medical research company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. The medical research company had revenue of $477.10 million for the quarter, compared to analyst estimates of $459.42 million. RadNet had a negative net margin of 1.73% and a positive trailing twelve-month return on equity of 1.41%. Read the conference call transcript. Who are RadNet's major shareholders? Top institutional investors of RadNet include Allspring Global Investments Holdings LLC (2.40%), Emerald Advisers LLC (0.90%), Global Alpha Capital Management Ltd. (0.84%) and Harbor Capital Advisors Inc. (0.57%). Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, Ranjan Jayanathan, David L Swartz, Lawrence L Levitt, Mark Stolper, David Jeffrey Katz, Cornelis Wesdorp, Michael N Murdock, Christine Nayoma Gordon and Gregory E Spurlock. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW). Company Calendar Last Earnings2/27/2025Today8/07/2025Next Earnings (Estimated)8/10/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:RDNT CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees11,021Year Founded1980Price Target and Rating Average Price Target for RadNet$69.60 High Price Target$80.00 Low Price Target$60.00 Potential Upside/Downside+32.5%Consensus RatingStrong Buy Rating Score (0-4)3.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E Ratio93.80 P/E GrowthN/ANet Income$2.79 million Net Margins-1.73% Pretax Margin0.44% Return on Equity1.41% Return on Assets0.48% Debt Debt-to-Equity Ratio0.87 Current Ratio2.01 Quick Ratio2.01 Sales & Book Value Annual Sales$1.83 billion Price / Sales2.15 Cash Flow$3.30 per share Price / Cash Flow15.92 Book Value$15.31 per share Price / Book3.43Miscellaneous Outstanding Shares75,030,000Free Float70,828,000Market Cap$3.94 billion OptionableOptionable Beta1.43 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:RDNT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.